SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000048
Filing Date
2023-09-26
Accepted
2023-09-26 16:32:27
Documents
15
Period of Report
2023-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20230920.htm   iXBRL 8-K 29674
2 EX-10.1 ex101-agreements.htm EX-10.1 191450
3 EX-99.1 ex991stack.htm EX-99.1 15938
7 PACIRA BIOSCIENCES LOGO pacirabiosciencesa.jpg GRAPHIC 27796
  Complete submission text file 0001396814-23-000048.txt   445033

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20230920.xsd EX-101.SCH 1911
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20230920_lab.xml EX-101.LAB 24134
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20230920_pre.xml EX-101.PRE 12518
9 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20230920_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 231280838
SIC: 2834 Pharmaceutical Preparations